COMPARISON OF OUTCOME IN METFORMIN WITH DAPAGLIFOZIN VERSUS METFORMIN WITH SITAGLIPTIN IN-TERM OF REDUCTION IN HBA1C IN TYPE 2 DIABETES MELLITUS. Frontier in Medical and Health Research, [S. l.], v. 3, n. 4, p. 1069–1073, 2025. Disponível em: https://fmhr.net/index.php/fmhr/article/view/1763.. Acesso em: 16 aug. 2026.